1. Home
  2. MASI vs RGEN Comparison

MASI vs RGEN Comparison

Compare MASI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Masimo Corporation

MASI

Masimo Corporation

HOLD

Current Price

$138.48

Market Cap

7.6B

Sector

Health Care

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$157.57

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MASI
RGEN
Founded
1989
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
8.2B
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
MASI
RGEN
Price
$138.48
$157.57
Analyst Decision
Buy
Buy
Analyst Count
6
10
Target Price
$188.80
$170.90
AVG Volume (30 Days)
765.7K
696.6K
Earning Date
11-04-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.03
Revenue
$2,182,000,000.00
$707,890,000.00
Revenue This Year
N/A
$17.84
Revenue Next Year
$6.83
$12.57
P/E Ratio
N/A
$6,185.26
Revenue Growth
38.48
11.74
52 Week Low
$133.70
$102.97
52 Week High
$194.88
$182.52

Technical Indicators

Market Signals
Indicator
MASI
RGEN
Relative Strength Index (RSI) 42.36 47.50
Support Level $137.00 $160.11
Resistance Level $142.70 $165.02
Average True Range (ATR) 4.81 4.97
MACD -0.39 -1.27
Stochastic Oscillator 19.81 7.12

Price Performance

Historical Comparison
MASI
RGEN

About MASI Masimo Corporation

Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: